Curtis J Henrich Selected Research

2- (4- ((4- amino- 2- methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid

3/2009

A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for "activator protein-1 hits".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Curtis J Henrich Research Topics

Disease

16	Neoplasms (Cancer) 01/2021 - 03/2006
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 11/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 08/2013
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 02/2014 - 01/2013
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Merkel Cell Carcinoma 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Experimental Melanoma 01/2021
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 05/2020
1	Lung Neoplasms (Lung Cancer) 10/2017
1	Astrocytoma (Pilocytic Astrocytoma) 11/2015
1	Hypoxia (Hypoxemia) 04/2015
1	Carcinoma (Carcinomatosis) 11/2014
1	Breast Neoplasms (Breast Cancer) 03/2009

Drug/Important Bio-Agent (IBA)

8	Biological ProductsIBA 01/2021 - 09/2011
4	Pharmaceutical PreparationsIBA 01/2021 - 02/2011
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2015
3	AlkaloidsIBA 11/2014 - 02/2014
2	LigandsIBA 01/2021 - 01/2017
2	LuciferasesIBA 01/2016 - 01/2012
2	Epithelial Cell Adhesion MoleculeIBA 01/2016 - 08/2013
2	PhytochemicalsIBA 02/2014 - 01/2013
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2012 - 02/2007
1	Poly I-CIBA 01/2021
1	PolynucleotidesIBA 01/2021
1	cerivastatin (Kazak)FDA Link 01/2021
1	physachenolide CIBA 01/2021
1	LimoninsIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 05/2020
1	rocaglamideIBA 11/2018
1	CamptothecinIBA 10/2017
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 10/2017
1	WithanolidesIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	discorhabdin WIBA 01/2016
1	discorhabdin HIBA 01/2016
1	makaluvamine FIBA 01/2016
1	discorhabdin LIBA 01/2016
1	discorhabdin BIBA 01/2016
1	DisulfidesIBA 01/2016
1	Pimozide (Orap)FDA Link 01/2016
1	Protein Synthesis InhibitorsIBA 01/2016
1	Antipsychotic Agents (Antipsychotics)IBA 01/2016
1	CateninsIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 04/2015
1	Oxygen (Dioxygen)IBA 04/2015
1	Molecular Probes (Molecular Probe)IBA 04/2015
1	Hypoxia-Inducible Factor 1IBA 04/2015
1	mirabilin GIBA 08/2014
1	Guanidine (Guanidine Nitrate)FDA Link 08/2014
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 04/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2014
1	4- (5- acetyloxy- 8,8- dimethyl- 6- (3- methylbut- 2- en- 1- yl)- 4- oxo- 4,8- dihydropyrano(2,3- f)chromen- 3- yl)- 1,2- phenylene diacetateIBA 04/2014
1	Sirolimus (Rapamycin)FDA Link 04/2014
1	LignansIBA 02/2014
1	QuassinsIBA 02/2014
1	CucurbitacinsIBA 01/2012
1	Complex MixturesIBA 01/2012
1	Apoptosis Regulatory ProteinsIBA 09/2011
1	matrigelIBA 03/2009
1	NF-kappa B (NF-kB)IBA 03/2009
1	2- (4- ((4- amino- 2- methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acidIBA 03/2009
1	Adenosine Triphosphate (ATP)IBA 03/2006
1	Cytotoxins (Cytolysins)IBA 03/2006

Therapy/Procedure

3	Therapeutics 01/2016 - 02/2007
1	Immunotherapy 01/2021